Sight Sciences, Inc.

SGHT·NasdaqGS·Healthcare
Compare
9.68+0.26 (+2.76%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.42
Open9.22
Day range8.9910.06
52-week range3.3810.06
Off day high−3.78%
Off 52-week high−3.78%
Volume629.73K
Avg. volume (3M)289.41K
Market cap533.25M
EPS (TTM)-0.5600
Forward P/E-24.19
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.40
Shares outstanding55.09M
Short interest3.09% of float
Earnings dateNov 4, 2026
Analyst target10.17
Profit margin−35.69%

Against its peers

Compare in full ›
SGHT REG1V.HE GKOS RXST LNSR IART
Market cap 533.25M 453.80M 14.60B 207.55M 71.75M 1.15B
P/E (TTM) — 26.3 — — 32.4 87.2
Forward P/E -24.2 14.0 176.2 -7.3 -11.5 6.2
Price/book 8.1 2.2 20.3 0.8 4.8 1.1
Dividend yield — — — — — —
1-year change +87.28% −51.49% +176.28% −44.96% −55.51% +19.56%
Today +2.76% −1.46% +5.86% +8.71% +4.85% +8.73%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All SGHT news ›
Defense World·

HC Wainwright Forecasts Sight Sciences Q3 Earnings

Sight Sciences, Inc. (NASDAQ:SGHT – Free Report) – Investment analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for Sight Sciences in a research note issued on Thursday, October 15th. HC Wainwright analyst…

Seeking Alpha·Positive

Sight Sciences: Signs Of Progress, But Plenty Of Work Remains

Sight Sciences is a cautious 'buy,' as recent reimbursement wins and product momentum support a positive outlook. Click to read more on the SGHT. - Sight Sciences is a cautious 'buy,' as recent reimbursement wins and product momentum…

From the 4Search news index, newest first.

In the news

13mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance